PubMed Health⌕ Search

PubMed · 16784030

[Laparoscopic colorectal surgery].

Abstract

Laparoscopic surgery have earned a firm place in the treatment of benign colon diseases. Concerning the treatment of malignant colorectal tumors the value of LAP surgery has evoked controversial assessments. On the basis of onco-surgical guidelines for colorectal carcinoma conventional standards began to sway. Independent factors like tumor stage, R0 resection, histological parameters and surgeon determine prognosis. Previous discussions about port site metastases and tumor cell dissemination by pneumoperitoneum have silenced. Several randomized studies have proven the short term superiority of LAP resection in term of postoperative pain management, bowel movement, hospital stay and rehabilitation over open methods. The late survival was as good, or better presented by some single center studies in the last five years. Newly, more multicentric randomized trials were conducted on late results of LAP surgery for malignant colorectal tumors which has been proved nonsignificantly better or equal to conventional surgery. Based on the above mentioned data laparoscopic colorectal surgery became an accepted option for treatment of colorectal carcinoma.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Péter Kupcsulik. 2006. [Laparoscopic colorectal surgery].. https://pubmed.ncbi.nlm.nih.gov/16784030/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Crohn's disease.

Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the gastrointestinal tract with extraintestinal manifestations and associated immune disorders. Genome wide association studies identified susceptibility loci that--triggered by environmental factors--result in a disturbed innate (ie, disturbed intestinal barrier, Paneth cell dysfunction, endoplasmic reticulum stress, defective unfolded protein response and autophagy, impaired recognition of microbes by pattern recognition receptors, such as nucleotide binding domain and Toll like receptors on dendritic cells and macrophages) and adaptive (ie, imbalance of effector and regulatory T cells and cytokines, migration and retention of leukocytes) immune response towards a diminished diversity of commensal microbiota. We discuss the epidemiology, immunobiology, amd natural history of Crohn's disease; describe new treatment goals and risk stratification of patients; and provide an evidence based rational approach to diagnosis (ie, work-up algorithm, new imaging methods [ie, enhanced endoscopy, ultrasound, MRI and CT] and biomarkers), management, evolving therapeutic targets (ie, integrins, chemokine receptors, cell-based and stem-cell-based therapies), prevention, and surveillance.

Colonic Diseases↗